CF Research and Translation Core Centers (P30)
The summary for the CF Research and Translation Core Centers (P30) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
CF Research and Translation Core Centers (P30): -The Cystic Fibrosis Research and Translation Core Center Program is designed to support both basic and clinical research on Cystic Fibrosis (CF). Core Centers provide shared resources to support research to develop and test new therapies for CF and foster collaborations among institutions with a strong existing research base in CF. The Center will also support pilot and feasibility studies to develop and test new approaches to therapy. -The NIDDK intends to commit $2,000,000 to this RFA. -The NIDDK anticipates issuing 2 awards. -This RFA will use the NIH core center research grant (P30) award mechanism. -Eligible organizations include for-profit or non-profit organizations, public or private institutions, units of state and local governments, eligible agencies of the federal government, and domestic institutions. -Eligible principal investigators include any individuals with the skills, knowledge, and resources necessary to carry out the proposed research. -Applicant organizations may submit only one application to this RFA. -See Section IV.1 for application materials. -Telecommunications for the hearing impaired is available at: TTY 301-451-0088
Federal Grant Title: | CF Research and Translation Core Centers (P30) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-DK-06-009 |
Type of Funding: | Grant |
CFDA Numbers: | 93.847 |
CFDA Descriptions: | Diabetes, Endocrinology and Metabolism Research |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Jul 21, 2006 |
Posted Date: | May 02, 2006 |
Creation Date: | May 04, 2006 |
Archive Date: | Aug 20, 2006 |
Total Program Funding: | $2,000,000 |
Maximum Federal Grant Award: | $750,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 2 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- City or township governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Special district governments State governments Public and State controlled institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) County governments
- Additional Information on Eligibility
- Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government can apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogen...
- • Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
- • Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors...
- • NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Requ...
- • NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements...
- • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
- • Molecular Therapy Core Centers
- • Pilot and Feasibility Program in Human Islet Biology
- More Grants from the National Institutes of Health
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
- • Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)